L.J. Altfest & Co’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,240
Closed -$54K 288
2021
Q2
$54K Buy
1,240
+19
+2% +$1.06K 0.01% 266
2021
Q1
$89K Buy
+1,221
New +$86.7K 0.02% 273

Other funds holding ORTX

L.J. Altfest & Co's ORTX Position: Q3 2021 in Review

L.J. Altfest & Co sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 1,240 shares — an estimated $54K sold.

L.J. Altfest & Co first reported a position in ORTX in Q1 2021 and held it in 2 quarters. The position peaked at $89K in Q1 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

  • L.J. Altfest & Co reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • L.J. Altfest & Co sold 1,240 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $54K.
  • L.J. Altfest & Co first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • L.J. Altfest & Co's Orchard Therapeutics plc American Depositary Shares position peaked at $89K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on L.J. Altfest & Co's 13F filing for Q3 2021, filed 12 Oct 2021.